Is Saxenda FDA Approved?
DrugStatusIndex provides a clear, data-driven view of the regulatory status of medications, compounds, and related products. This page explains whether Saxenda is FDA approved and how it is commonly categorized.
Overview
Saxenda is the brand name for liraglutide 3 mg, a prescription GLP-1 receptor agonist used for chronic weight management. It is prescribed for adults and certain adolescents with obesity or overweight plus weight-related medical conditions.
FDA Status Details
Saxenda is classified as FDA Approved. It received FDA approval for chronic weight management when used with reduced-calorie diet and increased physical activity.
Approved Use
Saxenda is approved for adults with obesity (BMI 30+) or overweight adults (BMI 27+) with at least one weight-related medical condition. It is also approved for certain pediatric patients aged 12 and older with obesity.
Prescription Status
Saxenda is an FDA-approved branded prescription medication and should be distinguished from compounded liraglutide products or non-approved peptide offerings marketed online.
Search Another Drug or Compound
Use DrugStatusIndex to review public regulatory status information for medications, compounds, and related products.